HealthEquity (HQY) Tops Q4 EPS by 7c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
HealthEquity, Inc (HQY) PT Raised to $97 at BofA Securities
March 20, 2024 4:41 AM EDTBofA Securities analyst Allen Lutz raised the price target on HealthEquity, Inc (NASDAQ: HQY) to $97.00 (from $93.00) while maintaining a Buy rating.
The analyst comments "HealthEquity reported a strong quarter, with strong expense management in Technology & Development the largest upside driver versus our model. FY25 revenue and EBITDA guidance was in line... More
HealthEquity, Inc (HQY) PT Raised to $110 at BTIG
March 20, 2024 4:11 AM EDTBTIG analyst David Larsen raised the price target on HealthEquity, Inc (NASDAQ: HQY) to $110.00 (from $100.00) while maintaining a Buy rating.
The analyst comments "On Tuesday, 3/19/24 AMC, HQY reported excellent F4Q:24 results. Total revenue of $262.4M +12% y/y exceeded BTIG / consensus estimates of $260.7M / $258.7M and adjusted EBITDA of $98.8M +34% y/y also exceeded BTIG / consensus estimates of $98M / $91.5M. HQY re-affirmed revenue guidance for... More
